Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer

Comment: Using enzalutamide will allow patients to avoid chemotherapy and steroids improving quality of life

Treating bladder problems for ovarian cancer patients

Filtering through the options: Renal considerations in disease management

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data

PIONEER research associates from both academic and industry discuss their experience of working together

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project

Denis Horgan explains the importance of actively engaging policy makers in PIONEER